BioXcel Therapeutics

Yahoo Finance • 2 months ago

Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions

Event Sponsored by BioXcel Therapeutics Set for 10 a.m. EST on Monday, Dec. 8 Topics Covered by Drs. Leslie Citrome, Marc Milano, and Leon Ravin to Include Opportunities and Advantages of Self-Administered Treatments at Home NEW HAVEN, C... Full story

Yahoo Finance • 2 months ago

BioXcel Therapeutics GAAP EPS of -$2.18 misses by $0.84

* BioXcel Therapeutics press release [https://seekingalpha.com/pr/20303392-bioxcel-therapeutics-reports-third-quarter-2025-financial-results-and-provides-update-on-late] (BTAI [https://seekingalpha.com/symbol/BTAI]): Q3 GAAP EPS of -$2.1... Full story

Yahoo Finance • 3 months ago

BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation

NEW HAVEN, Conn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company pioneering the use of artificial intelligence to develop transformative medicines in neuroscience, announced today... Full story

Yahoo Finance • 4 months ago

BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements

NEW HAVEN, Conn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it ha... Full story

Yahoo Finance • 4 months ago

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia

BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2 hours across 2,433 treated episodes (p<.05) Complete resolution of agitation was significantly higher with BXCL501 compared to placeb... Full story

Yahoo Finance • 5 months ago

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT STSSW [https://www.chartmill.com/stock/quote/STSSW/profile] 86.83%... Full story

Yahoo Finance • 5 months ago

Which stocks are experiencing notable movement on Wednesday?

Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT STSSW [https://ww... Full story

Yahoo Finance • 5 months ago

The market is filled with gapping stocks in Wednesday's session.

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT NBY [https://www.chartmill.com/sto... Full story

Yahoo Finance • 5 months ago

UPDATE -- BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®

BXCL501 achieved SERENITY At-Home’s primary endpoint of being well tolerated in the at-home treatment of agitation episodes in patients with bipolar disorders or schizophrenia No discontinuations for tolerability in the BXCL501 arm While... Full story

Yahoo Finance • 5 months ago

Form 8K BioXcel Therapeutics Inc For: 27 August

... Full story

Yahoo Finance • 5 months ago

Get insights into the top gainers and losers of Tuesday's after-hours session.

After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE... Full story

Yahoo Finance • 5 months ago

BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025

NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it wil... Full story

Yahoo Finance • 5 months ago

BioXcel Therapeutics Announces Database Lock in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

Data from more than 2,600 agitation episodes collected Topline data readout is on track for August NEW HAVEN, Conn., Aug. 19, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing art... Full story

Yahoo Finance • 5 months ago

These stocks are moving in today's pre-market session

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT V... Full story

Yahoo Finance • 5 months ago

Stocks Moving Premarket: PPCB, BTAI, TNXP, DAY, TPIC, And Other Gainers &amp; Losers

(RTTNews) - At 6.50 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening bell. For active traders, premarket trading offers a he... Full story

Yahoo Finance • 5 months ago

BioXcel Therapeutics Announces Positive FDA Pre-sNDA Meeting Comments for sNDA Submission for BXCL501 in Agitation Associated with Bipolar Disorders or Schizophrenia

Achieved alignment with the FDA on sNDA package to expand the IGALMI label for the At-Home (Outpatient) setting sNDA submission on track for Q1 2026 NEW HAVEN, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq... Full story

Yahoo Finance • 5 months ago

Wondering what's happening in today's after-hours session?

Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT DHAI [https://www.chartmill.com/stock/quote/DHAI/profile... Full story

Yahoo Finance • 5 months ago

BioXcel Therapeutics receives FDA feedback ahead of planned pre-sNDA meeting

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) announced Thursday that it has received preliminary comments from the U.S. Food and Drug Administration (FDA) in advance of a pre-supplemental New Drug Application (pre-sNDA) meeting scheduled for A... Full story

Yahoo Finance • 5 months ago

3 Supercharged Stocks Flashing Strong Momentum Signals

Several stocks have shown strong momentum in recent sessions as broader markets charge to all-time highs. Here’s a look at some standout momentum movers that are just starting to pick up steam. 3 Momentum Names To Watch Benzinga’s rankin... Full story

Yahoo Finance • 5 months ago

BioXcel at Canaccord Genuity: Strategic Insights on Phase 3 Trials

On Tuesday, 12 August 2025, BioXcel Therapeutics (NASDAQ:BTAI) participated in Canaccord Genuity’s 45th Annual Growth Conference, offering a strategic overview of its upcoming Phase 3 trial data for BXCL501. The company emphasized both its... Full story